Navigation Links
Labopharm to host webcast presentation on novel trazodone formulation for treatment of major depressive disorder
Date:11/24/2008

LAVAL, QC, Nov. 24 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that it will host a webcast presentation on Tuesday, December 16, 2008 at 10:00 am (ET) during which the Company's senior management team will discuss the product profile, clinical and regulatory progress and the market opportunity for its novel once-daily formulation of trazodone (DDS-04A), a serotonin antagonist reuptake inhibitor (SARI), for the treatment of major depressive disorder.

The webcast will also include presentations by two leading experts in the treatment of depression. Dr. Steven M. Stahl, adjunct Professor of Psychiatry at the University of California, San Diego, School of Medicine, will discuss the mechanism of action of trazodone and the value of SARIs in the treatment of depression. Dr. David V. Sheehan, Distinguished University Health Professor and Director of the Depression and Anxiety Disorders Research Institute at the University of South Florida College of Medicine, will review the clinical data from Labopharm's positive Phase III clinical trial for its novel trazodone formulation, including a presentation of additional data.

The live audio webcast will be available at www.labopharm.com. Please connect at least 15 minutes prior to the start time to ensure adequate time for any software download that may be required to join the webcast. The webcast will be archived at the above web site for 30 days.

About the Presenters

Dr. Stahl has conducted numerous research projects during his career and is awarded by the National Institute of Mental Health, by the Veterans Administration, and by the pharmaceutical industry. Author of more than 350 articles and chapters, Dr. Stahl is an internationally recognized clinician, r
'/>"/>

SOURCE Labopharm Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy
2. Labopharm provides update on U.S. regulatory process for once-daily Tramadol
3. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
4. Labopharm appeals FDAs decision on once-daily tramadol
5. Labopharm to host conference call Friday, November 9, 2007 at 8:30 a.m. (ET)
6. Labopharm to present at CIBC World Markets 18th Annual Healthcare Conference
7. Labopharm Reports Results for Third Quarter Fiscal 2007
8. Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol
9. Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova
10. Canadian Marketing and Sales Effort for Labopharms Once-Daily Tramadol Product to Expand Significantly
11. Labopharm Reports Positive Results for Phase III Study on Once-daily Trazodone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... attained the distinguished Magnet hospital designation by the ... Considered the gold standard for nursing excellence, the ... professionalism. It is the top international credential for ... Newport Hospital was based on the hospital,s continued ... , "It is a privilege for us to ...
(Date:8/22/2014)... may do little to help young people with drinking ... studies that included nearly 18,000 people 25 and younger, ... problems. Participants in 49 studies attended a single one-on-one ... studies attended group sessions or a mix of group ... interviewing was used in the studies. This technique was ...
(Date:8/22/2014)... previous few years, several breakthrough treatments have become ... who may benefit from these treatments can be ... their cancer. For example, patients whose lung cancer ... derive significant benefit from the drug crizotinib, which ... now attempting to replicate this success by matching ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 ItsHot.com, a ... now offering 60-80% off on its range of beautiful ... the purchase of Gold Hearts 14K White Rose Gold ... a discount of 77%. Previously priced at $3,715.00, ... $859.00. The item code of this mesmerizing pendant embedded ...
(Date:8/22/2014)... CA (PRWEB) August 22, 2014 “Dr. Luciana ... Luciana Lagana , aka Dr. Luciana, is finding it challenging ... budget and while taking care of hundreds of students, so ... trailer for the show is completed, and she recently entered ... fun projects including those of her husband, actor/screenwriter Gregory ...
Breaking Medicine News(10 mins):Health News:Newport Hospital receives nursing's highest credential for third time with Magnet recognition 2Health News:Counseling Does Little to Deter Youth Drinking, Review Finds 2Health News:Online screening for rare lung cancer subtypes opens door to new kind of clinical trial 2Health News:Online screening for rare lung cancer subtypes opens door to new kind of clinical trial 3Health News:Online screening for rare lung cancer subtypes opens door to new kind of clinical trial 4Health News:ItsHot.com Now Offers 60-80% Discount on its Striking Collection of Diamond Heart Pendants 2Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 2Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 3Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 4
... of new guidelines for cardiac specialists has been developed ... mechanical heart-pumping device. "The new guidelines will likely ... device, and how early in the process a physician ... Jeffrey A. Morgan, M.D., associate director of Mechanical Circulatory ...
... HealthDay Reporter , FRIDAY, April 15 (HealthDay News) -- ... showing early signs of dementia, researchers from the University of ... diagnose which type of dementia a patient has and start ... dementia patients tended to have difficulty identifying the form of ...
... By Steven Reinberg HealthDay Reporter , FRIDAY, ... chronic urinary tract infections, but now a new treatment ... a preliminary trial indicates. Urinary tract infections frequently ... all women. The depletion of vaginal Lactobacillus crispatus ...
... , FRIDAY, April 15 (HealthDay News) -- Teens who start ... traffic crashes, a new study finds. But starting the ... and reduce impulsiveness, another study finds. In 2008, the ... Beach, Va., was about 41 percent higher than for the ...
... Steven Reinberg HealthDay Reporter , THURSDAY, April 14 ... increase in hard times and decrease during years of prosperity, ... of people jumping from windows after the stock market crash ... the U.S. Centers for Disease Control and Prevention. "The ...
... A study in the April 15 issue of the Journal ... teen drivers who start school earlier in the morning. Results ... 18-year-olds was about 41 percent higher in Virginia Beach, Va., where ... adjacent Chesapeake, Va., where classes started at 8:40 - 8:45 a.m. ...
Cached Medicine News:Health News:Inability to Spot Lies, Sarcasm May Warn of Dementia 2Health News:Inability to Spot Lies, Sarcasm May Warn of Dementia 3Health News:New Treatment for Urinary Tract Infections Called Promising 2Health News:New Treatment for Urinary Tract Infections Called Promising 3Health News:Early School Start Tied to More Teen Crashes: Study 2Health News:Suicide Rates Rise and Fall With the Economy: CDC 2Health News:Suicide Rates Rise and Fall With the Economy: CDC 3Health News:Crash rates may be higher for teen drivers who start school earlier in the morning 2Health News:Crash rates may be higher for teen drivers who start school earlier in the morning 3
(Date:8/22/2014)... ITHACA, N.Y. , Aug. 22, 2014 /PRNewswire/ ... computed tomography (CT) imaging facility, is using the ... 4D and even 5D imaging to researchers and ... just launched, asks "What would YOU do if ... the possibility to researchers and explorers everywhere, from ...
(Date:8/22/2014)... 2014  WaferGen Bio-systems, Inc. (NASDAQ: WGBS) today announced ... of common stock and warrants at a price of ... prior to deducting underwriting discounts and commissions and offering ... are immediately separable and will be issued separately.  The ... on The NASDAQ Stock Market under the ticker symbol ...
(Date:8/21/2014)... 21, 2014  eRelevance Corporation ( www.erelevancecorp.com ), ... that it has completed integration with Nextech, a ... Surgery and Dermatology practices. "Integration allows ... healthcare practices using Nextech," stated Bob Fabbio ... information from the EMR we are able to ...
Breaking Medicine Technology:Cornell's X-ray Imaging Lab Director Uses Kickstarter Campaign to "Democratize" Advanced 3D Imaging 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 4eRelevance Corporation Integrates with Nextech Electronic Medical Records 2
Universal vacuum pump (capacity 34 L/min, 8 mbar vacuum abs.)...
... Combines BchiVac V-500 with Vacuum Controller V-800 ... switching mechanism turns V-500 on and off as needed ... Model V-500 is a powerful PTFE membrane ... Applications Ideally suited for use with up ...
... is a new addition to the powerful PTFE ... performance pump can achieve an ultimate vacuum of ... L/min. Applications For use with ... Distillation applications from lab size up to ...
... membrane vacuum pump designed to handle most vacuum ... use with up to two rotary evaporators ... ovens, concentrators, gel dryers, and filtration apparatuses ... to chemicals and heat load Corrosion-resistant ...
Medicine Products: